Envestnet Portfolio Solutions Inc. Sells 446 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Envestnet Portfolio Solutions Inc. lowered its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,435 shares of the biopharmaceutical company’s stock after selling 446 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in […]
Envestnet Portfolio Solutions Inc. lowered its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,435 shares of the biopharmaceutical company’s stock after selling 446 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in […]
